CROs Market Landscape in Drug Discovery and Preclinical services

CHALLENGE

A leading strategy consulting firm, in collaboration with a client in the pharmaceutical industry, is tasked with gaining a deeper understanding of the market for Contract Research Organizations (CROs) specializing in Drug Discovery and Preclinical services.

The objective is to evaluate the landscape, particularly in the US and Europe, and explore the market strategies employed by both biotech and pharmaceutical companies. The client's concerns involved a number of questions such as : Collaboration with CROs in developing new drugs, outsourcing different parts of the drug discovery process, and market perceptions of CRO services like "integrated projects" & related trends.

BTHT APPROACH

BTHT has embarked on a strategic analysis of the project's scope, meticulously examining key facets. The team is conducting an in-depth review of the competitive landscape within the realm of CROs, specifically those specializing in Drug Discovery and Preclinical services. This approach involves sourcing insights from industry professionals to gain a well-rounded perspective.

The research team is actively engaging with experts who possess substantial knowledge of the market dynamics and operational strategies in the United States and Europe. BTHT's portfolio for this project follows a dual approach :

- For Biotech, mid-sized, or large-sized pharma:

• Heads of Drug Discovery
• Heads of Preclinical Studies
• Heads of R&D
• Heads of CRO Relations
• External/Outsourcing Drug Discovery Managers

- For Drug Discovery & Preclinical CROs:

• Heads of Business Development
• C-level Executives (CEO, CSO, COO)
• Global Unit Managing Directors

The team managed to plan a series of targeted interviews, ensuring a balanced representation across both geographical regions within the two angles (Biotech/Pharma & CROs).

OUTCOME

BTHT's proactive and comprehensive approach aimed to deliver valuable insights for the client. Through focused consultations with industry experts who helped unravel the intricacies of the CRO landscape, enabling the client to make informed decisions, devise effective strategies, and navigate the complexities of Drug Discovery and Preclinical services in the United States and Europe.